Early-Phase Activation of Epithelial-Mesenchymal Transition in Lung Cancer Cells Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.

As opposed to what was achieved in the EGFR wild-type cells, the EGFR mutated ones revealed a decreasing trend in vimentin expression with values similar to control at 96 h of TGF-β exposure. 2.4.

also in 47,180 other papers